泛素耦联酶2C在乳腺癌中的作用及意义

doi:10.3760/cma.j.issn.1673-422X.2015.10.013

国际肿瘤学杂志 ›› 2015, Vol. 42 ›› Issue (10): 766-768.doi: 10.3760/cma.j.issn.1673-422X.2015.10.013

泛素耦联酶2C在乳腺癌中的作用及意义

秦涛,李曼

116023 大连医科大学附属第二医院肿瘤科

出版日期:2015-10-08 发布日期:2015-09-08
通讯作者: 李曼 E-mail:liman126126@163.com
基金资助:
辽宁省自然科学基金（2014023025）

Roles of UBE2C in breast cancer and its clinical significance

Qin Tao, Li Man.

Department of Medical Oncology, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China

Online:2015-10-08 Published:2015-09-08
Contact: Li Man E-mail:liman126126@163.com

摘要/Abstract

摘要： 泛素耦联酶2C（UBE2C）参与细胞周期进展、有丝分裂调控以及靶向降解短寿命的蛋白质。UBE2C是癌症相关的泛素耦联酶，其在乳腺癌组织中表达高于癌旁正常组织。异常表达的UBE2C通过调控细胞周期进展、CerbB2、细胞凋亡因子及转移相关因子等，参与乳腺癌发生、发展及转移的过程，并且可对乳腺癌的诊断及预后提供参考价值。

关键词: 细胞周期, 乳腺肿瘤, 泛素耦联酶2C

Abstract: Ubiquitinconjugating enzyme 2C (UBE2C) is involved in cell cycle progression, mitosis regulation and targeted degradation of shortlived proteins. UBE2C is the cancerrelated ubiquitinconjugating enzyme, which is significantly higher in breast cancer tissues compared to the adjacent normal tissue. The abnormal expression of UBE2C participates in the process of occurrence, development and metastasis of breast cancer by the regulation of cell cycle progression, CerbB2, cell apoptosis factors and metastasis related genes. It will provide reference for the diagnosis and prognosis of breast cancer.

Key words: Cell cycle, Breast neoplasms, Ubiquitinconjugating enzyme 2C

秦涛,李曼. 泛素耦联酶2C在乳腺癌中的作用及意义[J]. 国际肿瘤学杂志, 2015, 42(10): 766-768.

Qin Tao, Li Man.. Roles of UBE2C in breast cancer and its clinical significance[J]. Journal of International Oncology, 2015, 42(10): 766-768.

参考文献

［1］ Zhou MJ, Chen FZ, Chen HC. Ubiquitination involved enzymes and cancer［J］. Med Oncol, 2014, 31(8): 93. ［2］ Lin Y, Hwang WC, Basavappa R. Structural and functional analysis of the human mitoticspecific ubiquitinconjugating enzyme UbcH10［J］. J Biol Chem, 2002, 277(24): 21913-21921. ［3］ Nath S, Banerjee T, Sen D, et al. Spindle assembly checkpoint protein Cdc20 transcriptionally activates expression of ubiquitin carrier protein UbcH10［J］. J Biol Chem, 2011, 286(18): 15666-15677. ［4］ Meyer HJ, Rape M. Processive ubiquitin chain formation by the anaphasepromoting complex［J］. Semin Cell Dev Biol, 2011, 22(6): 544-550. ［5］ Rape M, Reddy SK, Kirschner MW. The processivity of multiubiquitination by the APC determines the order of substrate degradation［J］. Cell, 2006, 124(1): 89-103. ［6］ Hao Z, Zhang H, Cowell J. Ubiquitinconjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker［J］. Tumour Biol, 2012, 33(3): 723-730. ［7］ Berlingieri MT, Pallante P, Sboner A, et al. UbcH10 is overexpressed in malignant breast carcinomas［J］. Eur J Cancer, 2007, 43(18): 2729-2735. ［8］ Rawat A, Gopal G, Selvaluxmy G, et al. Inhibition of ubiquitin conjugating enzyme UBE2C reducesproliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole［J］. Cell Oncol, 2013, 36(6): 459-467. ［9］ Endesfelder D, Burrell R, Kanu N, et al. Chromosomal instability selects gene copy number variants encoding core regulators of proliferation in ER+ breast cancer［J］. Cancer Res, 2014, 74(17): 4853-4863. ［10］ Fujita T, Ikeda H, Kawasaki K, et al. Clinicopathological relevance of UbcH10 in breast cancer［J］. Cancer Sci, 2009, 100(2): 238-248. ［11］ Lu J, Wen M, Huang Y, et al. C2ORF40 suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes［J］. Epigenetics, 2013, 8(6): 571-583. ［12］ Wang S, Rijk JC, Pen MJ, et al. A lowdensity DNA microchip for the detection of (anti)estrogenic compounds and their relative potencies［J］. Analytical Biochemistry, 2013, 435(1): 83-92. ［13］ Lai HW, Chien SY, Kuo SJ, et al. The potential utility of curcumin in the treatment of HER2overexpressed breast cancer: an in vitro and in vivo comparison study with herceptin［J］. Evid Based Complement Alternat Med, 2012, 2012: 486568. ［14］王银平, 殷志强, 陈雪华. UbcH10在乳腺癌中的表达及意义［J］. 外科理论与实践, 2008, 13(2): 149-152. ［15］ Jancík S, Drábek J, Radzioch D, et al. Clinical relevance of KRAS in human cancers［J］. J Biomed Biotechnol, 2010, 2010: 150960. ［16］ Chou CP, Huang NC, Jhuang SJ, et al. Ubiquitinconjugating enzyme UBE2C is highly expressed in breast microcalcification lesions［J］. PLoS One, 2014, 9(4): e93934. ［17］ Loussouarn D, Campion L, Leclair F, et al. Validation of UBE2C protein as a prognostic marker in nodepositive breastcancer［J］. Br J Cancer, 2009, 101(1): 166-173. ［18］ Taylor KJ, Sims AH, Liang L, et al. Dynamic changes in gene expression in vivo predict prognosis of tamoxifentreated patients with breast cancer［J］. Breast Cancer Res, 2010, 12(3): R39.

[1]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[2]	萨蔷, 徐航程, 王佳玉. 乳腺癌免疫治疗研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 227-234.
[3]	杨智, 陆以乔, 顾花艳, 丁佳玲, 郭贵龙. 肿瘤微环境介导乳腺癌靶向治疗耐药的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 235-238.
[4]	陈波光, 王苏贵, 张永杰. 血清胆碱酯酶与炎症标志物在ⅠA~ⅢA期乳腺癌预后中的作用[J]. 国际肿瘤学杂志, 2024, 51(2): 73-82.
[5]	顾花艳, 朱腾, 郭贵龙. 乳房微生物群与乳腺癌：现状与未来[J]. 国际肿瘤学杂志, 2024, 51(1): 55-58.
[6]	王景, 许文婷. 中性粒细胞与淋巴细胞比值、癌胚抗原联合凝血指标对直径≤1.0 cm的良恶性乳腺结节鉴别诊断价值研究[J]. 国际肿瘤学杂志, 2023, 50(9): 520-526.
[7]	冯诚天, 黄芙蓉, 曹世玉, 王健宇, 南丁阿比雅思, 姜永冬, 朱娟英. HER2阳性乳腺癌患者HER2表达水平与影像学特征的关系[J]. 国际肿瘤学杂志, 2023, 50(9): 527-531.
[8]	冯东旭, 吴炜, 高平发, 王军, 施丽娟, 陈大伟, 李文兵, 张美峰. miR-451通过调控Rho/ROCK1信号通路对乳腺癌细胞糖酵解及凋亡的影响[J]. 国际肿瘤学杂志, 2023, 50(8): 449-456.
[9]	王文德, 曾德. 乳腺癌内分泌治疗耐药的机制研究进展[J]. 国际肿瘤学杂志, 2023, 50(6): 352-356.
[10]	李青珊, 谢鑫, 张楠, 刘帅. 放疗联合系统治疗在乳腺癌中的应用进展[J]. 国际肿瘤学杂志, 2023, 50(6): 362-367.
[11]	朱军, 黄美金, 李媛, 刘泽刚, 荀欣, 陈宏. HER2低表达乳腺癌的靶向治疗研究进展[J]. 国际肿瘤学杂志, 2023, 50(4): 236-240.
[12]	周婷, 徐少华, 梅林. 贝伐珠单抗联合卡培他滨治疗晚期乳腺癌的有效性及安全性[J]. 国际肿瘤学杂志, 2023, 50(3): 144-149.
[13]	黎立喜, 张娣, 罗扬, 马飞. PARP抑制剂在乳腺癌中的临床应用[J]. 国际肿瘤学杂志, 2023, 50(2): 91-96.
[14]	陈群响, 张晓钰, 张妍, 张凯翔, 李捷, 陈曦. 伊尼妥单抗联合长春瑞滨治疗HER2阳性转移性乳腺癌1例[J]. 国际肿瘤学杂志, 2023, 50(12): 763-765.
[15]	耿睿, 马俊强, 郭强, 牛钊峰. 老年乳腺癌患者的综合治疗方式选择倾向及其影响因素[J]. 国际肿瘤学杂志, 2023, 50(11): 650-654.

泛素耦联酶2C在乳腺癌中的作用及意义

Roles of UBE2C in breast cancer and its clinical significance

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价